Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Project details

Japanese new human absorbable painless micro needle company seeks C-round financing of USD 7.46 million - 11.18 million.

Project region Japan
Industry Healthcare
Total value of the target N/A
Expected target net rate of return after deducting all taxes and fees N/A
Validity period of pending order 365

CONTACT ADVISOR

  • Simon Laube

    Simon Laube

    Senior Associate, International Business Advisory

Project highlights optical and electrical technologies - painless needles - USD 5.29 million B-round
Project description

The Japanese company is mainly engaged in R&D and production of medical products with optical and electrical technologies. The main products are painless needles with laser processing technology, which can be used in skincare and beauty, medical anesthesia, preventive needles, and other fields. The company completed Round B+ financing at the end of 2020, with overall B-round financing of USD 5.29 million (JPY 710 million). It seeks Round C financing of USD 7.46 million - 11.18 million (JPY 1 billion - 1.5 billion) and plans to complete the IPO by the end of 2023.

Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive